Jeanette M. Broering, Ph.D.
Affiliations: | 2012 | Nursing | University of California, San Francisco, San Francisco, CA |
Area:
Nursing, Oncology, AgingGoogle:
"Jeanette Broering"Parents
Sign in to add mentorChristine Miaskowski | grad student | 2012 | UCSF | |
(Measurement Bias with Mixed-mode Patient-reported Outcome (PRO) Survey Administration: Measurement Equivalence, Cost, and Data Quality.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Braun AE, Chan JM, Neuhaus J, et al. (2024) The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable-risk prostate cancer. Cancer |
Herlemann A, Cowan JE, Washington SL, et al. (2023) Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer. European Urology |
Washington SL, Lonergan PE, Cowan JE, et al. (2023) Ten-year work burden after prostate cancer treatment. Cancer Medicine |
Baskin A, Cowan JE, Braun A, et al. (2023) Long-term complications and health-related quality of life outcomes after radical prostatectomy with or without subsequent radiation treatment for prostate cancer. Urologic Oncology |
Lonergan PE, Baskin A, Greenberg SA, et al. (2023) The long-term incidence and quality of life outcomes associated with treatment-related toxicities of external beam radiotherapy for prostate cancer. Urology |
Langlais CS, Graff RE, Van Blarigan EL, et al. (2023) Post-diagnostic health behaviour scores and risk of prostate cancer progression and mortality. British Journal of Cancer |
Smith LH, García-Albéniz X, Chan JM, et al. (2022) Emulation of a target trial with sustained treatment strategies: an application to prostate cancer using both inverse probability weighting and the g-formula. European Journal of Epidemiology |
Weng X, Zhong L, Xiang P, et al. (2022) Cost-effectiveness analysis of primary treatments for localised prostate cancer: A population-based Markov analysis using real-world evidence. European Journal of Cancer Care. e13740 |
Lonergan PE, Washington SL, Cowan JE, et al. (2021) Androgen Deprivation Therapy and the Risk of Dementia after Treatment for Prostate Cancer. The Journal of Urology. 101097JU000000000000 |
Langlais CS, Chan JM, Kenfield SA, et al. (2021) Post-diagnostic coffee and tea consumption and risk of prostate cancer progression by smoking history. Cancer Causes & Control : Ccc |